Elsevier

Neuroscience Letters

Volume 292, Issue 1, 29 September 2000, Pages 1-4
Neuroscience Letters

Amyloid β neurotoxicity not mediated by the mitogen-activated protein kinase cascade in cultured rat hippocampal and cortical neurons

https://doi.org/10.1016/S0304-3940(00)01415-4Get rights and content

Abstract

It has recently been reported that Alzheimer's disease amyloid β protein (Aβ) activates the mitogen-activated protein kinase (MAPK) cascade in certain types of cells. In the present study, we investigated whether this signal transduction cascade is involved in Aβ neurotoxicity by using cultured rat hippocampal and cortical neurons. Exposure of the cells to Aβ (1–20 μM) resulted in a progressive cell death with no change in phosphorylation of p44/42 MAPK (ERK1/2). Furthermore, Aβ-induced neuronal death was not at all affected by U0126 and PD98059, inhibitors of the MAPK-activating enzyme MEK. These results suggest that the MEK/ERK signal transduction cascade is not crucial for Aβ neurotoxicity.

References (22)

Cited by (38)

  • Schisantherin A recovers Aβ-induced neurodegeneration with cognitive decline in mice

    2014, Physiology and Behavior
    Citation Excerpt :

    Evidences also suggested that the overproduction of Aβ peptides, especially Aβ1–42, oxidative stress and apoptosis induced by Aβ play a critical role in the progressive of AD [9]. It has been demonstrated that Aβ is directly toxic to cultured neurons and also induces the neurodegenerative of the CA1 region of the hippocampus, and those findings supported the hypothesis that Aβ is involved in the neurodegenerative associated with AD [10–12]. Moreover, the synthetic Aβ seemed to be responsible for neurotoxic and oxidative events leading to neurodegenerative damage in hippocampal neurons and the cultured cortical neurons [13].

  • Dissociation of Akt/PKB and ribosomal S6 kinase signaling markers in a transgenic mouse model of Alzheimer's disease

    2008, Neurobiology of Disease
    Citation Excerpt :

    This result could explain the absence of modification of mTOR activation because Erk1/2 is the upstream regulator of mTOR. Other studies reported no alteration of Erk1/2 signaling in cellular models of AD (Abe and Saito, 2000; Ekinci et al., 1999). While the mTOR activation was not modified in brain of these double transgenic mice, we found a great activation of Akt, another upstream regulator of mTOR, with a robust accumulation of phosphorylated Akt at the catalytic site T308 in cytoplasm of neurons in hippocampal and cortical areas.

  • Cholesterol deficiency perturbs actin signaling and glutamate homeostasis in hippocampal astrocytes

    2006, Brain Research
    Citation Excerpt :

    As noted, the enhanced activation of ERK occurs in an astrocyte-specific manner. This is reminiscent of the finding that Aβ caused ERK activation in astrocytes, but not in neurons (Abe and Saito, 2000b). Abe and Saito previously reported that activation of Glu transporter led to phosphorylation of ERK in astrocytes (Abe and Saito, 2001).

View all citing articles on Scopus
View full text